Shimadzu upgrades CT and MRI platforms
Shimadzu Medical Systems has been busy since last year's RSNAmeeting upgrading CT and MRI scanners it introduced at that show.In MRI, the Torrance, CA, company will unveil three new models:Magnex Alpha II, Magnex 100/AP and Magnex 100/XP. Magnex Alpha II
Shimadzu Medical Systems has been busy since last year's RSNAmeeting upgrading CT and MRI scanners it introduced at that show.In MRI, the Torrance, CA, company will unveil three new models:Magnex Alpha II, Magnex 100/AP and Magnex 100/XP.
Magnex Alpha II is a 0.5-tesla scanner that improves on lastyear's Alpha platform with 14 millitesla/meter gradients, comparedto 10 mtesla/m gradients on Alpha. Magnex 100/AP and Magnex 100/XPare 1-tesla scanners. Magnex 100/XP is the more fully featuredmodel, with 15 mtesla/m gradients capable of one-second T2-weightedimaging. Both models have redesigned consoles that are similarto those of the Alpha line.
In CT, Shimadzu will again show the SCT-7000TX and SCT-7000THscanners, the vendor's first slip-ring scanners, which were introducedlast year.
In vascular imaging, Shimadzu will display new digital imagingcapabilities for the MH-100 ceiling-suspended C-arm, such as real-timesmooth mask (RSM), a work-in-progress technique in which the C-armmoves in a circular tomographic-style motion and acquires digitalsubtraction angiography (DSA) images at the same time.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
